How can the background of mRNA technology development help us understand how public vaccine research and development policy can be improved to generate the full global social benefits from breakthrough novel vaccine technologies?
The rocky start to the European Union’s vaccination rollout has allowed Moscow and Beijing to score political points in the Balkans and Central and Eastern Europe.
Progress has been made, but more progress is needed.
COVID-19 vaccination campaigns in the fastest-moving countries show signs of reinforcing inequality. European Union countries can avoid these pitfalls.
Aiming for 'green zones' offers a clear path to navigate an exit from the pandemic with as little damage as possible. Europe should not miss the opportunity to build on its strength and unity.
Europe was not prepared for the pandemic, but it must now learn lessons and use all its financial and political resources.
The appearance of new strains of the coronavirus in the United Kingdom, South Africa, and Brazil has given the world no choice but to design and implement a comprehensive global strategy. So, what's stopping that from happening?
“We have to open our mind, we have to look internationally. Because if we don’t, COVID-19 is going to stay with us.”
To the extent that vaccination against COVID-19 stops individuals infecting others, restrictions on vaccinated individuals’ rights should be lifted: fundamental freedoms should not be limited unnecessarily. Nevertheless, acceptance of vaccination passports depends on whether the vaccination allocation timeline is perceived as fair.
COVID-19 vaccination in Europe and the United States is moving too slowly and is failing to prevent avoidable death and economic disruption. More must be done to accelerate the campaign by targeting those most at risk.
The European Union’s purchases of frontrunner coronavirus vaccines are insufficient for the population’s near-term needs. The shortfall could have healthcare consequences and might delay economic reopening. Lessons should be learned for future pandemics.
Given the collapse in cooperation and of effective authority over health governance, what strategies should be pursued at international level, and by what means?